At a glance
Which J06 code do I assign?
The J06 codes cover an acute upper respiratory infection at multiple sites, or at a site the record does not name. Work down the anatomic sites in block J00–J06 before reaching for J06.9, because a named site always takes the site-specific code.
Tabular notes
Operational & financial impact
Why specificity matters beyond the chart: risk adjustment, DRG assignment and denial exposure all follow from which code is selected.
Documentation checklist to support J06.9
Chart elements that support code selection and reduce specificity-driven denials.
FAQ
Yes. J06.9 is a valid ICD-10-CM code and may be submitted on a claim for FY2027, effective 1 October 2026. It is the residual code in category J06. Use it only when no site-specific acute upper respiratory infection code fits the documentation.
J06.9 covers the upper respiratory tract: the nose, sinuses, pharynx and larynx. J20.9 is acute bronchitis, a lower respiratory tract infection. Chapter 10 of the tabular directs that a respiratory condition documented at more than one site, and not specifically indexed, is classified to the lower anatomic site. J06.9 and J22 carry reciprocal Excludes1 notes. The two are not reported together for the same condition.
No. J06.9 carries no CMS-HCC v28 payment condition category. An acute upper respiratory infection is self-limited, and the CMS-HCC models are built from conditions that predict the following year's costs. Severity designation under the MS-DRG grouper is a separate question from HCC mapping.
J06.9 is not coded where the provider documents COVID-19. Assign U07.1 instead. J06.9 describes an infection whose cause the record does not specify, and a documented COVID-19 diagnosis specifies it. The FY2027 Official Guidelines state that confirmation does not require a positive test result, and that the provider's documentation that the individual has COVID-19 is sufficient. Where the provider records suspected, possible, probable or inconclusive COVID-19, do not assign U07.1, and code the presenting signs and symptoms.
The FY2027 ICD-10-CM Official Guidelines, section I.C.1.g.1)(b), state that when COVID-19 meets the definition of principal diagnosis, U07.1 is sequenced first, followed by the appropriate codes for associated manifestations. Exceptions apply where another guideline requires a different code first, such as obstetrics, sepsis or transplant complications.
The note needs a provider statement of an acute upper respiratory infection. It also needs either an explicit finding that several upper airway sites are involved, or no named site at all. Record the organism where it is identified, which supports a secondary code from B95–B97. Where a single site is documented, the site-specific code from J00–J05 applies instead.
Yes. In the outpatient setting, code only a confirmed diagnosis, and code the presenting signs and symptoms where the diagnosis is documented as probable or suspected. On the inpatient side, UHDDS rules allow a diagnosis documented as uncertain at discharge to be coded as if it were confirmed. As a principal diagnosis on an inpatient claim, J06.9 groups to MS-DRG 152 or 153.
J06.9 is unchanged in the FY2027 update. Category J06 gained no new codes in the FY2026 update effective 1 October 2025. No J06 code was revised or deleted in that update. The FY2027 codes and tabular addenda, effective 1 October 2026, make no addition, deletion or revision in category J06 either.
Related codes
Codes in the same family as J06.9. Only codes with a published page render as links.
Sibling codes in the J06 family
- J06.0: Acute laryngopharyngitis.
Additional codes to consider
Codes outside the J06 family considered alongside J06.9.
Companion: code alongside when documented
- B95–B97: Bacterial and viral agents as the cause of diseases classified elsewhere, the Use Additional range named at J06.9.
- B97.4: Respiratory syncytial virus as the cause of diseases classified elsewhere.
- B97.89: Other viral agents as the cause of diseases classified elsewhere.
Consider instead
- J00: Acute nasopharyngitis [common cold], where the record documents a head cold.
- J01.90: Acute sinusitis, unspecified, where sinus involvement is documented.
- J02.9: Acute pharyngitis, unspecified, where the pharynx is the documented site.
- J02.0: Streptococcal pharyngitis, which category J06 excludes under Excludes1.
- J03.90: Acute tonsillitis, unspecified, where the tonsils are the documented site.
- J04.0: Acute laryngitis, where the larynx is the documented site.
- J05.0: Acute obstructive laryngitis [croup], where croup is documented.
- J20.9: Acute bronchitis, unspecified, a lower respiratory tract infection.
- J22: Unspecified acute lower respiratory infection, which carries a reciprocal Excludes1 with J06.9.
- J40: Bronchitis, not specified as acute or chronic.
- J11.1: Influenza due to unidentified influenza virus with other respiratory manifestations.
- R05.9: Cough, unspecified, where no diagnosis is established at the encounter.
- U07.1: COVID-19 replaces J06.9 where the provider documents a confirmed COVID-19 diagnosis.
Sources
All claims on this page derive from government and professional-standards sources.
- National Center for Health Statistics. (2026). International classification of diseases, tenth revision, clinical modification (ICD-10-CM) FY2027 files. https://www.cdc.gov/nchs/icd/icd-10-cm/files.html
- Centers for Medicare & Medicaid Services and National Center for Health Statistics. (2026). ICD-10-CM official guidelines for coding and reporting FY2027. https://ftp.cdc.gov/pub/Health_Statistics/NCHS/Publications/ICD10CM/2027/ICD-10-CM-October-1-2026-FY27-Guidelines.pdf
- Centers for Medicare & Medicaid Services. (2025). 2026 model software/ICD-10 mappings. https://www.cms.gov/medicare/payment/medicare-advantage-rates-statistics/risk-adjustment/2026-model-software-icd-10-mappings
- Centers for Medicare & Medicaid Services. (2026). MS-DRG classifications and software, version 44. https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/ms-drg-classifications-and-software
